| __timestamp | Ultragenyx Pharmaceutical Inc. | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 45967000 | 396000000 |
| Thursday, January 1, 2015 | 114737000 | 364000000 |
| Friday, January 1, 2016 | 183204000 | 376000000 |
| Sunday, January 1, 2017 | 231644000 | 382000000 |
| Monday, January 1, 2018 | 293998000 | 432000000 |
| Tuesday, January 1, 2019 | 357355000 | 457000000 |
| Wednesday, January 1, 2020 | 412084000 | 463000000 |
| Friday, January 1, 2021 | 497153000 | 508000000 |
| Saturday, January 1, 2022 | 705789000 | 539000000 |
| Sunday, January 1, 2023 | 648449000 | 614000000 |
| Monday, January 1, 2024 | 686000000 |
Data in motion
In the ever-evolving landscape of pharmaceuticals and animal health, innovation is the key to staying ahead. Over the past decade, Ultragenyx Pharmaceutical Inc. and Zoetis Inc. have demonstrated contrasting approaches to research and development (R&D) spending. From 2014 to 2023, Ultragenyx increased its R&D expenses by over 1,300%, peaking in 2022 with a staggering 705 million dollars. This reflects their aggressive pursuit of groundbreaking therapies. Meanwhile, Zoetis, a leader in animal health, maintained a steady growth in R&D, with a 55% increase over the same period, reaching 614 million dollars in 2023. This consistent investment underscores their commitment to innovation in veterinary medicine. As these companies continue to invest in R&D, their strategies highlight the diverse paths to success in the pharmaceutical industry.
Analyzing R&D Budgets: Eli Lilly and Company vs Zoetis Inc.
Research and Development: Comparing Key Metrics for Novartis AG and Zoetis Inc.
Analyzing R&D Budgets: Amgen Inc. vs Zoetis Inc.
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Biogen Inc.
Zoetis Inc. or Alpine Immune Sciences, Inc.: Who Invests More in Innovation?
Research and Development Investment: Zoetis Inc. vs Amneal Pharmaceuticals, Inc.
R&D Spending Showdown: Zoetis Inc. vs Ligand Pharmaceuticals Incorporated
Analyzing R&D Budgets: Zoetis Inc. vs Dynavax Technologies Corporation
R&D Spending Showdown: BioMarin Pharmaceutical Inc. vs Ultragenyx Pharmaceutical Inc.
R&D Spending Showdown: Ultragenyx Pharmaceutical Inc. vs MorphoSys AG
Who Prioritizes Innovation? R&D Spending Compared for Ultragenyx Pharmaceutical Inc. and Amphastar Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ultragenyx Pharmaceutical Inc. and MannKind Corporation